Grateful for our incredible team, the groundbreaking strides we’re making in the molecular glue space and unlocking new possibilities to shape a healthier future. This Thanksgiving, we celebrate the power of collaboration, innovation, and the endless potential of science.
Xiaoxi applies his expertise in chemical biology and medicinal chemistry to advance early platform efforts towards data-driven decisions and drive pipeline projects towards the clinic.
Honoring our nation’s heroes, past and present, for their bravery, sacrifice, and unwavering dedication. Happy Veteran’s Day. #veteransday#gratitude#service
Join us at the 6th Annual Targeted Protein Degradation Summit in Boston, MA next week! Our VP of Chemistry, Rohan Beckwith, will discuss the exciting expansion of the druggable genome using molecular glues. See you there! #TPDSummit#Biotech
A critical leader of early biology efforts, Sarah brings a team-focused philosophy, unwavering tenacity, and an infectious can-do attitude to Neomorph where she efficiently drives projects to data-driven decisions.
Are you attending the AACR International Conference on Molecular Targets and Cancer Therapeutics in Boston, MA this week? Neomorph’s VP of Molecular Sciences, Mary Matyskiela, Ph.D., will be presenting on expanding the druggable genome with molecular glues.
Walter pushes our protein degradation science by making tremendous efforts in our chemistry lab every day. In addition to being one of our talented chemists, Walter is also a great example and mentor for early-career chemists on the team.
Attending the Protein Degradation & Targeting Undruggables Congress Europe event in Basel, Switzerland next week? Neomorph’s VP of Molecular Sciences, Mary Matyskiela, will be presenting on approaches to molecular glue discovery.